Bottom line
Is MGRAX a good fund? The bottom line
MGRAX is a share class of MFS International Growth Fund, an actively managed international stock mutual fund from MFS.
It charges 1.04% — about $104 a year on every $10,000 invested, more expensive than 63% of international stock funds we track.
It returned +13.8% over one year, +5.6% a year over five years, +9.0% a year over ten (as of Dec 31, 2025, per its prospectus).
With $23.1 billion in net assets and 90 holdings, its largest position is Taiwan Semiconductor Manufacturing Co Ltd (7.2%) and the top 10 make up 34.3% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What stands out
- Large and established ($23.1 billion)
What to watch
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What MGRAX invests in
The funds investment objective is to seek capital appreciation.
MFS (Massachusetts Financial Services Company, the funds investment adviser) normally invests at least 80% of the funds net assets in growth companies. MFS defines growth companies as companies that MFS believes have above average earnings growth potential compared to other companies. MFS considers a number of factors when determining a companys growth potential, including whether (i) the issuer is included in an index that is representative of growth companies; (ii) the issuer is classified as a growth company by an independent third party financial data provider; and/or (iii) the issuer exhibits the characteristics of a growth company, considering metrics such as historical and/or projected earnings, sales, or free cash flow growth rates compared to the applicable equity market and/or to issuers in the same sector or industry. In assessing the growth potential of an issuer, MFS may…
From the fund's prospectus (filed Sep 25, 2026).
MGRAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MGRAX | +13.8% | +5.6% | +9.0% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What MGRAX costs
On a $10,000 investment, MGRAX's 1.04% expense ratio costs about $104 a year. The prospectus estimates $1,783 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
MGRAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Taiwan Semiconductor Manufacturing Co Ltd | 7.24% |
| 2 | Schneider Electric SE | 4.00% |
| 3 | Resonac Holdings Corp | 3.70% |
| 4 | Sap Se | 3.16% |
| 5 | Nestle SA | 2.97% |
| 6 | Delta Electronics Inc | 2.94% |
| 7 | AstraZeneca PLC | 2.79% |
| 8 | AIA Group Ltd | 2.67% |
| 9 | Rolls-Royce Holdings PLC | 2.40% |
| 10 | Agnico Eagle Mines Ltd | 2.38% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 34.3% of the fund. See all top 25 holdings and asset mix →